Holen Sie sich die Stockscreener-App
639.79
0.75%
-4.82
Handel nachbörslich:
639.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $750 - 富途牛牛
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating - marketscreener.com
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Finviz
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV) - The Globe and Mail
Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating - marketscreener.com
4 Analysts Have This To Say About IDEXX Laboratories - Benzinga
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market - Finviz
Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850 - marketscreener.com
Idexx Laboratories executive vice president sells $4.6 million in stock - MSN
IDEXX: A Great Business Trapped By A Demanding Valuation (NASDAQ:IDXX) - Seeking Alpha
Hantz Financial Services Inc. Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Alta Capital Management LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rep. April McClain Delaney Sells Off Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $730 to $805 - 富途牛牛
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results - Benzinga
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830 - marketscreener.com
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $730 - 富途牛牛
UBS Adjusts IDEXX Laboratories PT to $730 From $750 - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 earnings call transcript - MSN
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830 - marketscreener.com
Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700 - marketscreener.com
IDEXX Laboratories, Inc. $IDXX Shares Sold by Villere ST Denis J & Co. LLC - MarketBeat
Thrivent Financial for Lutherans Has $38.68 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories: Can This Quiet Diagnostics Powerhouse Still Surprise Wall Street? - AD HOC NEWS
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $800 - 富途牛牛
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 14.25% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Idexx Laboratories (IDXX) Margin Strength Reinforces Bullish Narrative Despite Premium P/E - Sahm
Earnings call transcript: IDEXX Labs Q4 2025 misses EPS, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: IDEXX Labs Q4 2025 misses EPS, stock dips - Investing.com Canada
IDEXX Laboratories (NASDAQ:IDXX) Trading Down 6.9%Should You Sell? - MarketBeat
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
IDEXX Laboratories Inc (IDXX) Q4 2025 Earnings Call Highlights: - GuruFocus
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise - The Globe and Mail
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
Why Is IDEXX Labs Stock Falling Today? - Benzinga
IDEXX Laboratories Q4 Earnings Call Highlights - MarketBeat
IDEXX Laboratories (IDXX) Reports Strong Q4 2025 Performance - GuruFocus
RSI Alert: Idexx Laboratories (IDXX) Now Oversold - Nasdaq
IDEXX Laboratories Reports 14% Q4 Revenue Growth Driven by Premium Instrument Placements - Market Business Insights
IDEXX falls 4% following in-line 2026 guidance - Seeking Alpha
IDEXX beats the Street on Q4 results, issues initial 2026 guidance - Mainebiz
AI for investors - MLQ.ai
IDEXX Laboratories (NASDAQ:IDXX) Updates FY 2026 Earnings Guidance - MarketBeat
Earnings Summary: IDEXX Laboratories Q4IDEXX Laboratories (NASDAQ:IDXX) - Benzinga
IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares - Reuters
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics - marketscreener.com
Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
IDEXX Laboratories (IDXX) Q4 FY25 sales rise in double digits - AlphaStreet
IDEXX Laboratories (NASDAQ:IDXX) Announces Quarterly Earnings Results - MarketBeat
IDEXX LABORATORIES INC (NASDAQ:IDXX) Reports Strong Q4 2025 Earnings Beat, Issues Cautious 2026 Outlook - Chartmill
IDEXX Laboratories Earnings Report: Q4 Overview - Benzinga
IDEXX Laboratories Q4 Comparable Earnings, Revenue Rise; Issues 2026 Guidance - marketscreener.com
Idexx: Q4 Earnings Snapshot - Bitget
IDEXX LABS ($IDXX) Releases Q4 2025 Earnings - Quiver Quantitative
IDEXX Laboratories Guides FY26 In Line With EstimatesUpdate - Nasdaq
IDEXX Laboratories Q4 Earnings Assessment - Benzinga
1.61%
2.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):